Sopharma Trading AD Past Earnings Performance

Past criteria checks 3/6

Sopharma Trading AD has been growing earnings at an average annual rate of 6.5%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 15.2% per year. Sopharma Trading AD's return on equity is 14.1%, and it has net margins of 1%.

Key information

6.5%

Earnings growth rate

5.2%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate15.2%
Return on equity14.1%
Net Margin1.0%
Last Earnings Update31 Mar 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Sopharma Trading AD makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:6YH Revenue, expenses and earnings (BGN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 221,37813990
31 Dec 211,3368980
30 Sep 211,33315970
30 Jun 211,26913880
31 Mar 211,19012790
31 Dec 201,15611720
30 Sep 201,06810640
30 Jun 201,01710640
31 Mar 201,00211650
31 Dec 199469630
30 Sep 199298620
30 Jun 199169610
31 Mar 199019610
31 Dec 188889610
30 Sep 188668610
30 Jun 188258600
31 Mar 187768570
31 Dec 177219540
30 Sep 1766910500
30 Jun 1764210460
31 Mar 1762611450
31 Dec 1661311420
30 Sep 1660210410
30 Jun 1660411400
31 Mar 1660311390
31 Dec 1560311380
30 Sep 1559812370

Quality Earnings: 6YH has a high level of non-cash earnings.

Growing Profit Margin: 6YH's current net profit margins (1%) are lower than last year (1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6YH's earnings have grown by 6.5% per year over the past 5 years.

Accelerating Growth: 6YH's earnings growth over the past year (12.2%) exceeds its 5-year average (6.5% per year).

Earnings vs Industry: 6YH earnings growth over the past year (12.2%) exceeded the Healthcare industry -16.1%.


Return on Equity

High ROE: 6YH's Return on Equity (14.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies